Docetaxel Trihydrate (Standard)

(Synonyms: RP-56976 Trihydrate (Standard))

Docetaxel Trihydrate (Standard) (RP-56976 Trihydrate (Standard)) is the analytical standard of Docetaxel Trihydrate (HY-B0011A). This product is intended for research and analytical applications. Docetaxel Trihydrate (RP-56976 Trihydrate) is an orally active tubulin stabilizer with antitumor activity. Docetaxel Trihydrate is a P-glycoprotein substrate and is metabolized by CYP3A to inactive products. Docetaxel Trihydrate binds tubulin, promotes tubulin polymerization, and inhibits microtubule depolymerization. Docetaxel Trihydrate induces aberrant mitosis followed by necrotic-like cell death at low concentrations, and induces G2/M mitotic arrest and drives apoptosis at high concentrations. Docetaxel Trihydrate induces renal injury/renal alterations, sex-dependent granule toxicity/uptake, low cardiac delivery, and decreased hepatic SOD/increased catalase/hepatotoxicity. Docetaxel Trihydrate can be used in cancer-related research.

For research use only. We do not sell to patients.

  • Purity : 98%
  • CAS No.: 148408-66-6
  • Formula: C43H59NO17
  • Molecular Weight:861.93
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Product Information
  • Chemical Information
  • Purity & Documentation
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00